Young Age, Liver Dysfunction, and Neurostimulant Use as Independent Risk Factors for Post-Traumatic Seizures: A

Nicodemus Edrick Oey1, Pei Ting Tan2, Shrikant Digambarrao Pande2

  • 1Rehabilitation Medicine, SingHealth Residency, Singapore 169608, Singapore.

Insights

Younger traumatic brain injury (TBI) patients with low GCS scores, cerebral contusions, or neurostimulant use face higher seizure risks. Close monitoring for post-TBI seizures is crucial for these individuals.

Area of Science:

  • Neurology
  • Neurosurgery
  • Trauma Care

Background:

  • Traumatic brain injury (TBI) can lead to long-term neurological deficits, including seizures.
  • Identifying modifiable risk factors for post-TBI seizures is essential for improving patient outcomes.
  • Previous research has explored various factors, but a comprehensive analysis of modifiable risks is still needed.

Purpose of the Study:

  • To identify potentially modifiable risk factors predicting seizures after traumatic brain injury.
  • To investigate the relationship between seizure risk and injury severity, interventions, and comorbidities.

Main Methods:

  • Retrospective study of 151 patients with TBI admitted between March 2008 and October 2017.
  • Analysis of data from 141 patients with complete follow-up records and no prior history of seizures.
  • Statistical analysis to identify factors associated with the development of post-TBI seizures.

Main Results:

  • 33 out of 141 patients (24.4%) developed seizures post-TBI.
  • Younger age, presence of cerebral contusions, Indian race, low Glasgow Coma Scale (GCS) scores, and neurostimulant use were associated with increased seizure risk.
  • Neurosurgical interventions were also noted in the context of increased seizure risk.

Conclusions:

  • Younger TBI patients, those with low GCS scores, cerebral contusions, or on neurostimulants require vigilant monitoring for post-TBI seizures.
  • The association between neurostimulant use and increased seizure risk warrants further investigation.
  • Understanding these risk factors can guide targeted monitoring and management strategies for TBI patients.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
240
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
512
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
394
Post-traumatic Stress Disorder01:27

Post-traumatic Stress Disorder

Post-traumatic stress disorder (PTSD) is a psychiatric condition that arises following exposure to traumatic events such as natural disasters, forced displacement, or severe accidents. It significantly impairs individuals' ability to cope with daily activities and disrupts their emotional and psychological equilibrium.
Symptoms and Behavioral Manifestations
A spectrum of distressing symptoms characterizes PTSD. Recurrent flashbacks, where individuals involuntarily relive traumatic events,...
81
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
104
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
498